Impressum, Vol. 19, No. 6, 1996
R. Parwaresch, B. Bültmann, Y. Bankmann, Margret Rave‐Fränk, T. Wiegel, Wolfgang E. Berdel(University Hospital Münster), Walter Hoffmann, D. Comely, Martin Busch, C. Degner, D.K. Hossfeld, M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), A. Korfel, Katharina Holstein, T.M.M. de Reijke, M. Schiebe, I.-M. von Broen, T.A. Walter, N. Runkel, U. Vogel, K. H. Kurth, T. Franke, H.J. Weh, K. Mross, D. H. J. Schamhart, Elizabeth C. de Boer, P. Rudolph, M. Bamberg, Kenneth D. Herbst, E. Dühmke
Cited by 0
Related Papers
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654